These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26083214)

  • 81. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.
    Cosnes J; Nion-Larmurier I; Beaugerie L; Afchain P; Tiret E; Gendre JP
    Gut; 2005 Feb; 54(2):237-41. PubMed ID: 15647188
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The TREAT Registry: Evolution of Knowledge From 1999 to 2017: Lessons Learned.
    Lichtenstein GR
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1319-1321. PubMed ID: 28554680
    [No Abstract]   [Full Text] [Related]  

  • 83. Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease.
    Ardizzone S; Bevivino G; Monteleone G
    Therap Adv Gastroenterol; 2016 Jul; 9(4):527-32. PubMed ID: 27366221
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease.
    Monteleone G; Di Sabatino A; Ardizzone S; Pallone F; Usiskin K; Zhan X; Rossiter G; Neurath MF
    Aliment Pharmacol Ther; 2016 Mar; 43(6):717-24. PubMed ID: 26766141
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Targeting SMAD7 in Crohn's Disease by Mongersen: Therapeutic Revolution Under Way?
    Danese S; Fiorino G; Peyrin-Biroulet L
    Gastroenterology; 2015 Oct; 149(4):1121-3. PubMed ID: 26319033
    [No Abstract]   [Full Text] [Related]  

  • 86. Ca2+ enrichment in culture medium potentiates effect of oligonucleotides.
    Hori S; Yamamoto T; Waki R; Wada S; Wada F; Noda M; Obika S
    Nucleic Acids Res; 2015 Oct; 43(19):e128. PubMed ID: 26101258
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Editorial: mongersen in Crohn's disease--a new contribution to the beginning of a long-awaited therapeutic revolution?
    Kirchgesner J; Sokol H
    Aliment Pharmacol Ther; 2016 Apr; 43(7):838-9. PubMed ID: 26932411
    [No Abstract]   [Full Text] [Related]  

  • 88. Where are we heading to in pharmacological IBD therapy?
    Rogler G
    Pharmacol Res; 2015 Oct; 100():220-7. PubMed ID: 26277232
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitis.
    Hagan M; Cross RK
    Expert Opin Drug Saf; 2015; 14(9):1473-9. PubMed ID: 26138111
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis.
    Rutgeerts P; Feagan BG; Marano CW; Padgett L; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Zhang H; Colombel JF; Reinisch W; Gibson PR; Sandborn WJ;
    Aliment Pharmacol Ther; 2015 Sep; 42(5):504-14. PubMed ID: 26119226
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Oligonucleotide Therapies: The Past and the Present.
    Lundin KE; Gissberg O; Smith CI
    Hum Gene Ther; 2015 Aug; 26(8):475-85. PubMed ID: 26160334
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Positioning Therapy for Ulcerative Colitis.
    Grinspan A; Kornbluth A
    Curr Gastroenterol Rep; 2015 Aug; 17(8):29. PubMed ID: 26143627
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Efficacy of the new infliximab biosimilar CT-P13 induction therapy in Crohn's disease and ulcerative colitis - experiences from a single center.
    Farkas K; Rutka M; Bálint A; Nagy F; Bor R; Milassin Á; Szepes Z; Molnár T
    Expert Opin Biol Ther; 2015; 15(9):1257-62. PubMed ID: 26134250
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Patients with Active Luminal Crohn's Disease Have Evidence of Significant Functional and Clinical Pulmonary Involvement.
    Peerani F; Choi M; Weinkauf J; Fedorak RN; Halloran B
    Inflamm Bowel Dis; 2015 Aug; 21(8):1817-24. PubMed ID: 26086595
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The TGF-β/Smad System in IBD Pathogenesis.
    Sedda S; Marafini I; Dinallo V; Di Fusco D; Monteleone G
    Inflamm Bowel Dis; 2015 Dec; 21(12):2921-5. PubMed ID: 26230862
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.
    Lazzerini M; Martelossi S; Magazzù G; Pellegrino S; Lucanto MC; Barabino A; Calvi A; Arrigo S; Lionetti P; Lorusso M; Mangiantini F; Fontana M; Zuin G; Palla G; Maggiore G; Bramuzzo M; Pellegrin MC; Maschio M; Villanacci V; Manenti S; Decorti G; De Iudicibus S; Paparazzo R; Montico M; Ventura A
    Inflamm Bowel Dis; 2015 Aug; 21(8):1739-49. PubMed ID: 26185909
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Development and Application of an Ultrasensitive Hybridization-Based ELISA Method for the Determination of Peptide-Conjugated Phosphorodiamidate Morpholino Oligonucleotides.
    Burki U; Keane J; Blain A; O'Donovan L; Gait MJ; Laval SH; Straub V
    Nucleic Acid Ther; 2015 Oct; 25(5):275-84. PubMed ID: 26176274
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Good results: antisense-oligonucleotide Mongersen is in Crohn's disease].
    Moskaleva M
    Dtsch Med Wochenschr; 2015 May; 140(10):710-1. PubMed ID: 26171473
    [No Abstract]   [Full Text] [Related]  

  • 99. Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission.
    Amiot A; Hulin A; Belhassan M; Andre C; Gagniere C; Le Baleur Y; Farcet JP; Delchier JC; Hüe S
    Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):90-8. PubMed ID: 26138132
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Conventional Versus Biological Therapy for Prevention of Postoperative Endoscopic Recurrence in Patients With Crohn's Disease: an International, Multicenter, and Observational Study.
    Kotze PG; Spinelli A; da Silva RN; de Barcelos IF; Teixeira FV; Saad-Hossne R; de Albuquerque IC; Olandoski M; da Silva Kotze LM; Suzuki Y; Yamada A; Takeuchi K; Sacchi M; Yamamoto T
    Intest Res; 2015 Jul; 13(3):259-65. PubMed ID: 26131001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.